Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIntelligent Medicine Acquisition Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/17/2023 | Q4 2022 | $0.55 | $0 | |||
| 11/14/2022 | Q3 2022 | $0.05 | $0 | |||
| 08/15/2022 | Q2 2022 | $0.11 | $0 | |||
| 05/17/2022 | Q1 2022 | $210,924.00 | $0 | |||
| 03/30/2022 | Q4 2021 | $0.00 | $0 | |||
| 12/20/2021 | Q3 2021 | $0.00 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.00 | $0 |
Intelligent Medicine Acquisition Corp. Earnings: FAQ's
When is Intelligent Medicine Acquisition Corp.'s earnings date?
Intelligent Medicine Acquisition Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 30th, 2022 based off last year's report dates.
How can I listen to Intelligent Medicine Acquisition Corp.'s earnings conference
call?
The conference call for Intelligent Medicine Acquisition Corp.'s latest earnings report can be listened to online.
How can I read Intelligent Medicine Acquisition Corp.'s conference call transcript?
The conference call transcript for Intelligent Medicine Acquisition Corp.'s latest earnings report can be read online.
How much profit does Intelligent Medicine Acquisition Corp. generate each year?
Intelligent Medicine Acquisition Corp. (:IQMD) has a recorded net income of $0. Intelligent Medicine Acquisition Corp. has generated $2.2 earnings per share over the last four quarters.
What is Intelligent Medicine Acquisition Corp.'s price-to-earnings ratio?
Intelligent Medicine Acquisition Corp. (:IQMD) has a price-to-earnings ratio of 5.01 and price/earnings-to-growth ratio is 0.05.